Asahi Kasei Bioprocess Europe
Asahi Kasei Bioprocess Europe, a subsidiary of the renowned Asahi Kasei Corporation, is headquartered in Belgium and operates extensively across Europe. Established in the early 2000s, the company has made significant strides in the bioprocessing industry, focusing on innovative solutions for biopharmaceutical manufacturing. Specialising in advanced filtration and purification technologies, Asahi Kasei Bioprocess Europe offers unique products such as the AFS® and AFS®-M series, which are designed to enhance efficiency and reliability in bioprocessing applications. Their commitment to quality and innovation has positioned them as a leader in the market, serving a diverse clientele in the life sciences sector. With a strong emphasis on sustainability and customer-centric solutions, Asahi Kasei Bioprocess Europe continues to achieve notable milestones, reinforcing its reputation as a trusted partner in the bioprocessing landscape.
DitchCarbon Score
How does Asahi Kasei Bioprocess Europe's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asahi Kasei Bioprocess Europe's score of 26 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Asahi Kasei Bioprocess Europe's reported carbon emissions
Asahi Kasei Bioprocess Europe reported significant carbon emissions in 2019, totalling approximately 11,500,000,000 kg CO2e across all scopes. This includes about 2,960,000,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and around 1,030,000,000 kg CO2e from Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, approximately 11,500,000,000 kg CO2e, fall under Scope 3, which encompasses indirect emissions in the value chain. Notably, significant contributors to Scope 3 emissions include purchased goods and services (about 4,740,000,000 kg CO2e) and the end-of-life treatment of sold products (approximately 4,980,000,000 kg CO2e). Despite the substantial emissions figures, Asahi Kasei Bioprocess Europe has not publicly disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented reduction strategies suggests a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | |
|---|---|
| Scope 1 | 2,960,000,000 |
| Scope 2 | 1,030,000,000 |
| Scope 3 | 11,500,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asahi Kasei Bioprocess Europe is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
